Patients | Year | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 |
Men | |||||||||||||
All men | Total aged ⩾35 years (n) | 269 419 | 296 809 | 323 843 | 342 122 | 365 610 | 387 357 | 406 756 | 433 640 | 439 816 | 426 380 | 387 509 | 369 351 |
Number with IHD code ever | 20 448 | 22 844 | 25 220 | 26 588 | 28 757 | 30 912 | 32 678 | 35 229 | 36 018 | 34 991 | 31 855 | 30 079 | |
Percentage of men* | 7.57 | 7.68 | 7.78 | 7.81 | 7.92 | 8.05 | 8.12 | 8.22 | 8.28 | 8.27 | 8.25 | 8.14 | |
- receiving no treatment in year† | 43.2 | 38.3 | 34.0 | 29.8 | 25.1 | 20.2 | 16.4 | 13.3 | 10.7 | 7.9 | 5.5 | 5.0 | |
- combination treatment in year‡ | 0.8 | 1.9 | 3.8 | 6.6 | 10.8 | 15.7 | 21.2 | 27.3 | 34.1 | 42.1 | 50.3 | 54.7 | |
Non-specific IHD or angina only | Number | 9 619 | 10 519 | 11 481 | 11 929 | 12 702 | 13 511 | 14 095 | 15 034 | 15 111 | 14 225 | 12 564 | 11 576 |
Percentage of all male IHD | 47.0 | 46.0 | 45.5 | 44.9 | 44.2 | 43.7 | 43.1 | 42.7 | 42.0 | 40.7 | 39.4 | 38.5 | |
- receiving no treatment in year† | 48.6 | 44.4 | 39.9 | 36.0 | 31.6 | 26.1 | 21.6 | 17.8 | 14.5 | 11.1 | 8.0 | 7.2 | |
- combination treatment in year‡ | 0.4 | 1.0 | 2.0 | 3.6 | 6.1 | 10.1 | 14.4 | 19.5 | 25.0 | 32.4 | 40.4 | 44.7 | |
MI or revascularis- ation only | Number | 10 829 | 12 325 | 13 739 | 14 659 | 16 055 | 17 401 | 18 583 | 20 195 | 20 907 | 20 766 | 19 291 | 18 503 |
Percentage of male IHD | 53.0 | 54.0 | 54.5 | 55.1 | 55.8 | 56.3 | 56.9 | 57.3 | 58.0 | 59.3 | 60.6 | 61.5 | |
- receiving no treatment in year† | 37.9 | 32.8 | 28.7 | 24.4 | 19.7 | 15.4 | 12.4 | 9.7 | 7.8 | 5.7 | 3.8 | 3.6 | |
- combination treatment in year‡ | 1.1 | 2.6 | 5.2 | 9.0 | 14.4 | 20.0 | 26.3 | 33.1 | 40.6 | 48.7 | 56.7 | 61.0 | |
Women | |||||||||||||
All women | Total aged ⩾35 years | 299 363 | 32 8431 | 356 946 | 374 762 | 399 133 | 420 285 | 440 797 | 468 322 | 473 367 | 456 509 | 414 099 | 394 174 |
Number with IHD code ever | 15 156 | 17 136 | 18 932 | 19 760 | 21 118 | 22 463 | 23 846 | 25 670 | 26 032 | 24 797 | 22 154 | 20 661 | |
Percentage of women* | 4.88 | 5.04 | 5.12 | 5.12 | 5.17 | 5.26 | 5.34 | 5.44 | 5.49 | 5.44 | 5.35 | 5.24 | |
- receiving no treatment in year† | 48.2 | 43.5 | 38.9 | 34.6 | 29.7 | 24.6 | 20.7 | 17.1 | 14.2 | 10.9 | 7.9 | 7.0 | |
- combination treatment in year‡ | 0.5 | 1.2 | 2.6 | 4.4 | 7.4 | 11.4 | 15.9 | 20.9 | 26.3 | 33.5 | 42.4 | 45.9 | |
Non-specific IHD or angina only | Number | 10 764 | 12 049 | 13 204 | 13 670 | 14 517 | 15 379 | 16 193 | 17 356 | 17 424 | 16 322 | 14 244 | 13 103 |
Percentage of all female IHD | 71.0 | 70.3 | 69.7 | 69.2 | 68.7 | 68.5 | 67.9 | 67.6 | 66.9 | 65.8 | 64.3 | 63.4 | |
- receiving no treatment in year† | 52.3 | 47.7 | 43.4 | 38.7 | 33.8 | 28.4 | 24.0 | 20.1 | 16.8 | 13.0 | 9.4 | 8.7 | |
- combination treatment in year‡ | 0.3 | 0.7 | 1.4 | 2.6 | 4.6 | 7.8 | 11.3 | 15.5 | 20.4 | 26.8 | 35.9 | 39.1 | |
MI or revascularis- ation only | Number | 4 392 | 5 087 | 5 728 | 6 090 | 6 601 | 7 084 | 7 653 | 8 314 | 8 608 | 8 475 | 7 910 | 7 558 |
Percentage of all female IHD | 29.0 | 29.7 | 30.3 | 30.8 | 31.3 | 31.5 | 32.1 | 32.4 | 33.1 | 34.2 | 35.7 | 36.6 | |
- receiving no treatment in year† | 38.0 | 33.6 | 28.7 | 25.2 | 20.7 | 16.5 | 13.8 | 10.7 | 8.8 | 6.8 | 5.0 | 4.1 | |
- combination treatment in year‡ | 1.0 | 2.4 | 5.3 | 8.3 | 13.6 | 19.4 | 25.6 | 32.2 | 38.0 | 46.3 | 54.2 | 57.7 |
Results are shown as percentages unless stated otherwise.
*Age-adjusted rate.
†No statins, antiplatelet drugs, β-blockers, or ACE inhibitors in year (age-adjusted).
‡Statins, antiplatelets and β-blockers or ACE inhibitors in year (age-adjusted).